1057 related articles for article (PubMed ID: 15908296)
1. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study.
Dreno B; Foulc P; Reynaud A; Moyse D; Habert H; Richet H
Eur J Dermatol; 2005; 15(3):152-5. PubMed ID: 15908296
[TBL] [Abstract][Full Text] [Related]
2. Erythromycin-resistance of cutaneous bacterial flora in acne.
Dreno B; Reynaud A; Moyse D; Habert H; Richet H
Eur J Dermatol; 2001; 11(6):549-53. PubMed ID: 11701406
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
Song M; Seo SH; Ko HC; Oh CK; Kwon KS; Chang CL; Kim MB
J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337
[TBL] [Abstract][Full Text] [Related]
4. Clinical and bacteriological evaluation of nadifloxacin 1% cream in patients with acne vulgaris: a double-blind, phase III comparison study versus erythromycin 2% cream.
Plewig G; Holland KT; Nenoff P
Eur J Dermatol; 2006; 16(1):48-55. PubMed ID: 16436342
[TBL] [Abstract][Full Text] [Related]
5. Effects of topical erythromycin on aerobic and anaerobic surface flora.
Bernstein JE; Shalita AR
Acta Derm Venereol; 1980; 60(6):537-9. PubMed ID: 6162344
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic-resistant Propionibacterium acnes among acne patients in a regional skin centre in Hong Kong.
Luk NM; Hui M; Lee HC; Fu LH; Liu ZH; Lam LY; Eastel M; Chan YK; Tang LS; Cheng TS; Siu FY; Ng SC; Lai YK; Ho KM
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):31-6. PubMed ID: 22103749
[TBL] [Abstract][Full Text] [Related]
7. Contribution to the interpretation of the occurrence of unsuccessful therapeutical results in acne vulgaris with topical erythromycin (Propionibact. acnes).
Gloor M; Lamerz A; Franke-Hoffman M
Zentralbl Bakteriol A; 1981 Feb; 248(4):502-8. PubMed ID: 6452774
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility of Propionibacterium acnes isolated from acne vulgaris.
Kurokawa I; Nishijima S; Kawabata S
Eur J Dermatol; 1999; 9(1):25-8. PubMed ID: 9920982
[TBL] [Abstract][Full Text] [Related]
9. Bacterial resistance in French acne patients.
Dumont-Wallon G; Moyse D; Blouin E; Dréno B
Int J Dermatol; 2010 Mar; 49(3):283-8. PubMed ID: 20465665
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility and genetic characteristics of Propionibacterium acnes isolated from patients with acne.
Schafer F; Fich F; Lam M; Gárate C; Wozniak A; Garcia P
Int J Dermatol; 2013 Apr; 52(4):418-25. PubMed ID: 23432195
[TBL] [Abstract][Full Text] [Related]
11. [The resistance of Propionibacterium acnes and Staphylococcus epidermidis to cyclines. The Research and Study Group on Acne].
Noyon V; Legallou F; Richet H; Dreno B
Ann Dermatol Venereol; 1998 Dec; 125(12):885-7. PubMed ID: 9922860
[TBL] [Abstract][Full Text] [Related]
12. Nasal antibiotic-resistant Propionibacterium acnes carriage in acne vulgaris patients in Turkey.
Ergin C; Ergin S; Kaleli I; Kaçar N; Sengül M; Erdoğan BS
J Dermatol; 2006 Dec; 33(12):899-901. PubMed ID: 17169100
[No Abstract] [Full Text] [Related]
13. Antibiotic resistance of microbial strains isolated from Korean acne patients.
Moon SH; Roh HS; Kim YH; Kim JE; Ko JY; Ro YS
J Dermatol; 2012 Oct; 39(10):833-7. PubMed ID: 22779738
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility of Propionibacterium acnes isolates from acne patients in Colombia.
Mendoza N; Hernandez PO; Tyring SK; Haitz KA; Motta A
Int J Dermatol; 2013 Jun; 52(6):688-92. PubMed ID: 23451873
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibilities of Propionibacterium acnes isolated from patients with acne vulgaris.
Ishida N; Nakaminami H; Noguchi N; Kurokawa I; Nishijima S; Sasatsu M
Microbiol Immunol; 2008 Dec; 52(12):621-4. PubMed ID: 19120976
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory effects of erythromycin and tetracycline on Propionibacterium acnes induced production of chemotactic factors and reactive oxygen species by human neutrophils.
Jain A; Sangal L; Basal E; Kaushal GP; Agarwal SK
Dermatol Online J; 2002 Oct; 8(2):2. PubMed ID: 12546757
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility of strains of Propionibacterium acnes isolated from inflammatory acne.
Gübelin W; Martínez MA; Molina MT; Zapata S; Valenzuela ME
Rev Latinoam Microbiol; 2006; 48(1):14-6. PubMed ID: 17357569
[TBL] [Abstract][Full Text] [Related]
18. [Skin reactions to antigens of propionibacterium acnes in patients with acne vulgaris treated with autovaccine].
Załuga E
Ann Acad Med Stetin; 1998; 44():65-85. PubMed ID: 9857532
[TBL] [Abstract][Full Text] [Related]
19. Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action.
Pollock B; Turner D; Stringer MR; Bojar RA; Goulden V; Stables GI; Cunliffe WJ
Br J Dermatol; 2004 Sep; 151(3):616-22. PubMed ID: 15377348
[TBL] [Abstract][Full Text] [Related]
20. The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin-resistant propionibacteria.
Eady EA; Bojar RA; Jones CE; Cove JH; Holland KT; Cunliffe WJ
Br J Dermatol; 1996 Jan; 134(1):107-13. PubMed ID: 8745894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
